Wall Street Analysts See an 88.94% Upside in Bicycle Therapeutics (BCYC): Can the Stock Really Move This High?

Bicycle Therapeutics PLC Sponsored ADR (BCYC) closed the last trading session at $22.96, gaining 3.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $43.38 indicates an 88.9% upside potential.The mean estimate comprises eight short-term price targets with a standard deviation of $12.91. While the lowest estimate of $28 indicates a 22% increase from the current price level, the mos ...